Giuseppe Giugliano Selected Research

Giuseppe Giugliano Research Topics

4	Hypertension (High Blood Pressure) 01/2022 - 07/2006
4	Stroke (Strokes) 01/2019 - 01/2008
3	Thrombosis (Thrombus) 07/2022 - 01/2019
3	Myocardial Infarction 02/2018 - 01/2008
2	Hemorrhage 01/2022 - 01/2017
2	Acute Coronary Syndrome 09/2020 - 01/2018
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2019 - 12/2018
2	Left Ventricular Dysfunction 01/2019 - 12/2018
2	Pathologic Constriction (Stenosis) 01/2019 - 01/2017
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018 - 03/2017
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2018 - 01/2017
2	Aortic Valve Stenosis (Aortic Stenosis) 09/2014 - 09/2014
1	Methylenetetrahydrofolate reductase deficiency 07/2022
1	Neoplasms (Cancer) 01/2022
1	Ischemia 04/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2021
1	Heart Diseases (Heart Disease) 01/2019
1	Carotid Artery Diseases 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Inflammation (Inflammations) 01/2018
1	Hypertrophy 01/2018
1	Dementia (Dementias) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Isolated Systolic Hypertension 03/2017
1	Obesity 03/2017
1	Chronic Limb-Threatening Ischemia 01/2017
1	Vascular Diseases (Vascular Disease) 01/2017
1	Intermittent Claudication 01/2017
1	Infarction (Infarctions) 09/2015
1	Mitral Valve Insufficiency (Mitral Regurgitation) 09/2014
1	Aortic Dissection 10/2009
1	Peripheral Arterial Disease 01/2008
1	Hyperglycemia 07/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2006
1	Hypertriglyceridemia 07/2006
1	Abdominal Obesity 07/2006

3	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 10/2009
2	Octreotide (Sandostatin)FDA LinkGeneric 01/2019 - 12/2018
1	Sirtuin 1IBA 07/2022
1	ResveratrolIBA 07/2022
1	AcidsIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	NADPH Oxidase 2IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	sphingosine kinaseIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	sortilinIBA 01/2022
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2022
1	Dobutamine FDA LinkGeneric 04/2021
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2018
1	GlycosphingolipidsIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	GalactosidasesIBA 01/2018
1	AntioxidantsIBA 01/2018
1	Adenosine Monophosphate (AMP)IBA 01/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018
1	Carvedilol (Coreg)FDA LinkGeneric 01/2018
1	salicylhydroxamic acid (SHAM)IBA 09/2015
1	dicarboxydine (DCD)IBA 09/2015
1	dermcidinIBA 09/2015
1	MyokinesIBA 09/2015
1	Peptides (Polypeptides)IBA 09/2015
1	Small Interfering RNA (siRNA)IBA 09/2015
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2008
1	C-Reactive ProteinIBA 01/2008
1	Peroxidase (Myeloperoxidase)IBA 01/2008
1	HDL LipoproteinsIBA 07/2006

4	Therapeutics 09/2020 - 10/2009
3	Stents 01/2019 - 06/2016
2	Secondary Prevention 01/2022 - 01/2019
2	Length of Stay 01/2019 - 01/2017
2	Transcatheter Aortic Valve Replacement 09/2014 - 09/2014
1	Percutaneous Coronary Intervention 02/2018
1	Palliative Care (Palliative Therapy) 01/2017
1	Endovascular Procedures 01/2017
1	Ligation 09/2015